Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 114
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin, Hodgkin Disease, Multiple Myeloma Trial in United States (TXA127, Placebo)

Terminated
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Duarte, California
  • +9 more
Dec 7, 2020

Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Bakersfield, California
  • +58 more
Oct 15, 2020

Multiple Myeloma Trial in United States (Lenalidomide)

Completed
Has Results
  • Multiple Myeloma
  • Tucson, Arizona
  • +41 more
Apr 27, 2020

Multiple Myeloma Trial in United States (High-Dose Melphalan HCL for Injection (Propylene Glycol-Free), Autologous

Completed
  • Multiple Myeloma
  • High-Dose Melphalan HCL for Injection (Propylene Glycol-Free)
  • Autologous Transplantation
  • Chicago, Illinois
  • +5 more
Apr 15, 2020

Cancer, Hematologic Malignancies, Multiple Myeloma Trial in Worldwide (Denosumab, Zoledronic acid, Placebo to Denosumab)

Completed
Has Results
  • Cancer
  • +5 more
  • Tucson, Arizona
  • +308 more
Mar 19, 2020

Acute Myeloid Leukemia, Multiple Myeloma, Diffuse Large B-cell Lymphoma Trial in France, Korea, Republic of, United States

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Los Angeles, California
  • +13 more
Feb 27, 2020

Cancer, Breast Cancer, NSCLC Trial in United States (ABBV-075, Venetoclax)

Completed
  • Cancer
  • +7 more
  • Scottsdale, Arizona
  • +9 more
Nov 27, 2019

Multiple Myeloma Trial in Worldwide (Lenalidomide and low-dose dexamethasone, Lenalidomide plus low-dose dexamethasone given for

Completed
Has Results
  • Multiple Myeloma
  • Lenalidomide and low-dose dexamethasone
  • +2 more
  • Birmingham, Alabama
  • +287 more
Nov 7, 2019

Multiple Myeloma Trial in United States (CC-5013)

Completed
  • Multiple Myeloma
  • Glendale, Arizona
  • +25 more
Nov 7, 2019

Multiple Myeloma Trial in Chicago (radiation, procedure, drug)

Terminated
Has Results
  • Multiple Myeloma
  • Total Marrow Irradiation
  • +3 more
  • Chicago, Illinois
    UIC Cancer Center
Sep 23, 2019

Multiple Myeloma Trial in United States (BT062)

Completed
Has Results
  • Multiple Myeloma
  • Atlanta, Georgia
  • +4 more
Jul 22, 2019

Multiple Myeloma Trial in United States (BT062 , intravenous administration)

Completed
  • Multiple Myeloma
  • BT062 , intravenous administration
  • Duarte, California
  • +9 more
Jul 22, 2019

S0702: Osteonecrosis of Jaw in Cancer Receiving Zoledronic Acid

Completed
  • Breast Cancer
  • +6 more
  • assessment of therapy complications
  • Anniston, Alabama
  • +452 more
Jul 3, 2019

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Berkeley, California
  • +19 more
Mar 20, 2019

MMRF Molecular Profiling Protocol

Recruiting
  • Multiple Myeloma
  • Plasma Malignancy
  • genetic sequencing
  • Scottsdale, Arizona
  • +19 more
Mar 15, 2019

Multiple Myeloma Trial in San Francisco, Atlanta, Chicago (Panobinostat, Carfilzomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • San Francisco, California
  • +2 more
Jan 14, 2019

Multiple Myeloma Trial in Worldwide (Daratumumab)

Approved for marketing
  • Multiple Myeloma
  • Phoenix, Arizona
  • +78 more
Jan 11, 2019

Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous Leukemia Trial in Chicago (fludarabine/busulfan, fludarabine/

Completed
Has Results
  • Acute Myeloid Leukemia
  • +10 more
  • Chicago, Illinois
    University of Illinois at Chicago Medical Center
Oct 9, 2018

Multiple Myeloma, Plasma Cell Tumor Trial in United States (Lenalidomide, Dexamethasone, Anticoagulants)

Terminated
Has Results
  • Multiple Myeloma
  • Plasma Cell Neoplasm
  • Scottsdale, Arizona
  • +15 more
Sep 22, 2018

Multiple Myeloma Trial in Worldwide (ABBV-838, Pomalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Chicago, Illinois
  • +18 more
Sep 12, 2018

Multiple Myeloma Trial in Canada, United States (ASP7487, Velcade, Dexamethasone)

Terminated
Has Results
  • Multiple Myeloma
  • ASP7487, Velcade, Dexamethasone
  • Atlanta, Georgia
  • +5 more
Sep 12, 2018

Multiple Myeloma to Personal Assessment of Genetic Profile

Active, not recruiting
  • Multiple Myeloma
    • Scottsdale, Arizona
    • +72 more
    Aug 14, 2018

    Multiple Myeloma Trial in Worldwide (GSK2110183, Bortezomib, Dexamethasone)

    Completed
    • Multiple Myeloma
    • Scottsdale, Arizona
    • +12 more
    Aug 6, 2018

    Multiple Myeloma Trial in Canada, Spain, United States (Daratumumab 16 mg/kg (Part 1), Daratumumab 8 mg/kg (Part 1),

    Completed
    Has Results
    • Multiple Myeloma
    • Daratumumab 16 mg/kg (Part 1)
    • +5 more
    • Duarte, California
    • +22 more
    Jun 21, 2018

    Multiple Myeloma Trial in Worldwide (Elotuzumab, Bortezomib, Dexamethasone)

    Completed
    Has Results
    • Multiple Myeloma
    • Elotuzumab
    • +2 more
    • Corona, California
    • +76 more
    Apr 20, 2018